Personalized Unit Dose Manufacturing With Networked Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for fulfilling prescriptions lack customization and efficiency in producing individual unit doses (IUDs) tailored to a specific individual's medical needs, often relying on government-approved dosage amounts and lacking FDA verification, especially for off-label uses and compounded drugs.
Innovation Solution
A system and method for manufacturing personalized IUDs using a network-enabled control system that measures biometrics, communicates health information, and produces IUDs directly from a manufacturer according to a patient's prescription, ensuring quality control and efficient delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If personalized IUDs are manufactured according to individual prescriptions, then patient-specific medical needs are met, but manufacturing complexity and cost increase
Solution Approach 1:
The manufacturing system is divided into separate functional modules: biometric measurement module, network communication module, and IUD manufacturing apparatus. Each module operates independently but connects through the network, allowing personalized customization without requiring complete system redesign for each patient.
Solution Approach 2:
The system accepts variable input parameters (biometric data, prescription details) and dynamically adjusts manufacturing parameters accordingly. This allows the same manufacturing apparatus to produce different personalized IUDs by changing operational parameters based on received prescription data.
2Reliability
If IUDs are manufactured with government-approved dosages only, then regulatory compliance is ensured, but patient-specific dosage requirements cannot be met
Solution Approach 1:
The network system acts as an intermediary between regulatory requirements and patient needs. It receives and validates prescription data, ensuring compliance with regulations while transmitting personalized dosage requirements to the manufacturing apparatus, thus bridging the gap between standardized compliance and individualized treatment.
3Adaptability or versatility
If pharmacies compound medications individually, then patient customization is achieved, but manufacturing quality and consistency deteriorate
Solution Approach 1:
The patent replaces manual compounding processes with an automated manufacturing apparatus controlled by digital prescription data. This substitution of mechanical/manual operations with automated systems ensures consistent, precise dosage delivery while maintaining the ability to customize each unit according to patient needs.
4Productivity
If pharmacies maintain large inventories of IUDs, then prescription fulfillment speed increases, but overhead costs and waste increase
Solution Approach 1:
The system performs preliminary actions by receiving and processing prescription data before manufacturing begins. This allows the manufacturing apparatus to be pre-configured with specific parameters, enabling rapid production startup without requiring large inventories to be maintained in advance.
Solution Approach 2:
The manufacturing system operates on-demand based on received prescriptions, effectively serving itself by producing only what is needed. This eliminates the need for maintaining large inventories, as the system can quickly manufacture personalized IUDs when prescriptions are received.
Data Source
AI summary
Systems and methods for making and delivering personalized, medically prescribed pharmaceuticals to an individual patient are described. Individual unit doses (IUDs) of medicine may be prepared specific to the individual in need of same, by using a system, which includes a networked control system in combination with manufacturing assemblies specific to the IUDs and delivering the medicine to the patient directly from the manufacturer.